What is Chardan Capital’s Estimate for UBX FY2025 Earnings?
Unity Biotechnology, Inc. (NASDAQ:UBX – Free Report) – Equities researchers at Chardan Capital lowered their FY2025 earnings per share estimates for Unity Biotechnology in a research report issued on Wednesday, April 23rd. Chardan Capital analyst D. Gataulin now forecasts that the company will earn ($0.91) per share for the year, down from their prior estimate […]
